Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
Chapter 3. Non-invasive Aesthetic Treatment Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing beauty consciousness among consumers
3.2.1.2. Growing geriatric population
3.2.2. Market Restraint Analysis
3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat from new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Social Landscape
3.3.2.3. Technology Landscape
3.3.2.4. Legal Landscape
3.4. COVID Impact Analysis
Chapter 4. Non-invasive Aesthetic Treatment Market: Segment Analysis, By Procedure, 2018 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure market share analysis, 2022 & 2030
4.3. Global Non-invasive Aesthetic Treatment Market, By Procedure, 2018 - 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
4.4.1. Injectables
4.4.2.皮肤恢复活力
4.4.3. Others
Chapter 5. Non-invasive Aesthetic Treatment Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. End Use market share analysis, 2022 & 2030
5.3. Global Non-invasive Aesthetic Treatment Market, By End Use, 2018 - 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030for the following
5.4.1. Hospital/Surgery Center
5.4.2. Medspa
5.4.3.传统的温泉
5.4.4. HCP owned clinic
Chapter 6. Non-invasive Aesthetic Treatment Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2022 & 2030
6.3. Regional Market Dashboard
6.4. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
6.5. North America
6.5.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
6.5.2. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.5.3. U.S.
6.5.3.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.5.4. Canada
6.5.4.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
6.6.2. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.4. U.K.
6.6.4.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.5. France
6.6.5.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.6. Italy
6.6.6.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.7. Spain
6.6.7.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.9. Sweden
6.6.9.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.6.10. Norway
6.6.10.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
6.7.2. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7.3. China
6.7.3.1.市场估计和预测,通过procedure, 2018 - 2030 (USD Million)
6.7.4. Japan
6.7.4.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7.5. India
6.7.5.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7.7. South Korea
6.7.7.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.7.8. Australia
6.7.8.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
6.8.2. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.8.3. Brazil
6.8.3.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.8.4. Mexico
6.8.4.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.8.5. Argentina
6.8.5.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.9. Middle East and Africa
6.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
6.9.2. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.9.3. South Africa
6.9.3.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.9.4. Saudi Arabia
6.9.4.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.9.5. UAE
6.9.5.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
6.9.6. Kuwait
6.9.6.1. Market estimates and forecast, by procedure, 2018 - 2030 (USD Million)
Chapter 7. Non-invasive Aesthetic Treatment Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Hologic, Inc.
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Allergan, Inc.
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3.Galderma S.A.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Alma Lasers
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Syneron Candela
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Johnson & Johnson
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Merz Pharma
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Lumenis
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Solta Medical
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Cutera Inc
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives.
7.1.11. Revance Therapeutics Inc.
7.1.11.1. Company overview
7.1.11.2. Financial performance
7.1.11.3. Product benchmarking
7.1.11.4. Strategic initiatives.
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviation
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Non-invasive aesthetic treatment market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Non-invasive aesthetic treatment market: procedure movement analysis
Fig. 16 Regional marketplace: Key takeaways
Fig. 17 Regional outlook, 2022 & 2030
Fig. 18 North America Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 19 U.S. Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 20 Canada Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million))
Fig. 21 Europe Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 22 U.K. Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 23 Germany Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 24 Italy Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 25 Spain Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 26 Denmark Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 27 Sweden Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 28 Norway Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 29 France Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 30 Asia Pacific Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 31 Japan Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 32 China Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 33 India Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 34 Thailand Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 35 South Korea Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 36 Australia Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 37 Latin America Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 38 Brazil Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 39 Mexico Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 40 Argentina Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 41 MEA Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 42 South Africa Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 43 Saudi Arabia Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 44 UAE Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 45 Kuwait Non-invasive aesthetic treatment market, 2018 - 2030 (USD Million)